Zura Bio Limited

ZURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.58

+$0.08 (+1.78%)

Sep 22, 2026, 11:07 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $427.49M

Enterprise Value $222.36M

Beta -0.04

Average Volume 1.15M

Shares Outstanding (Diluted) 126.8M

Shares Change YoY 34.48%

Institutional Ownership 58.86%

Exchange NASDAQ

ISIN KYG9TY5A1016

Price Performance

Price Change 1M -22.6%

Price Change 3M 4.4%

Price Change 6M -19.9%

Price Change YTD -18.9%

Price Change 1Y 113.3%

Price Change 3Y -29.7%

Price Change 5Y -84.7%

1M CAGR (ann.) -24.6%

1Y CAGR (ann.) 119.5%

5Y CAGR (ann.) N/A

All-Time CAGR -12.7%

Valuation

PE Ratio -3.98

Forward PE N/A

PEG Ratio 0.08

Forward PEG 0.44

PS Ratio N/A

Forward PS 45.60

PB Ratio 2.17

P/FCF Ratio -5.51

P/Adj. FCF Ratio -4.77

P/OCF Ratio -7.38

EV/Sales N/A

EV/EBIT -2.59

EV/EBITDA -2.59

EV/FCF -2.86

Earnings Yield -25.1%

FCF Yield -18.2%

Adj. FCF Yield -21.0%

Financial Health

Net Cash $205.13M

Total Debt $0

Cash & Short-Term Investments $205.13M

Total Assets $213.4M

Current Ratio 12.90

Quick Ratio 12.90

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 13.68

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -15.5%

Returns

Return on Assets -40.2%

Return on Equity -55.0%

Return on Invested Capital -47.0%

Return on Capital Employed -47.1%

Return on Tangible Assets -40.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -34.5%

EPS CAGR 5Y -6.5%

EPS CAGR 10Y N/A

FCF CAGR 3Y -53.3%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y -0.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.22

EPS Growth Est (next Q) 4.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $20

Price Target Upside 344.4%

Cash Flow

Operating Cash Flow $-77.55M

Free Cash Flow $-77.63M

Adj. Free Cash Flow $-89.67M

FCF Per Share -$0.61

OCF Per Share -$0.61

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-16K

Operating Income $-92.75M

EBITDA $-85.75M

Net Income $-85.74M

EPS (Diluted) -$1.13

Revenue / Employee N/A

Profit / Employee $-2.14M

Employees 40